-
1 Comment
Nanjing Well Pharmaceutical Group Co.,Ltd is currently in a long term downtrend where the price is trading 10.9% below its 200 day moving average.
From a valuation standpoint, the stock is 58.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.
Nanjing Well Pharmaceutical Group Co.,Ltd's total revenue sank by 19.6% to $179M since the same quarter in the previous year.
Its net income has dropped by 46.4% to $18M since the same quarter in the previous year.
Finally, its free cash flow fell by 492.2% to $-73M since the same quarter in the previous year.
Based on the above factors, Nanjing Well Pharmaceutical Group Co.,Ltd gets an overall score of 1/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | SHG |
CurrencyCode | CNY |
ISIN | CNE100003JD4 |
Target Price | None |
---|---|
Market Cap | 4B |
PE Ratio | 25.49 |
Beta | 0.38 |
Dividend Yield | None |
Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables. The company also provides synthetic base oils, such as hydraulic fluids, lubricity additives for metals, metal quenching, base fluids and lubricity additives, synthetic base for compress lubricants, synthetic base oil for gear, base oil of chain lubricants, base stock of engine oil, base stock of heat transfer oil, and base oil of grease; and other products, including painting and coating, textile chemicals, field chemicals, and low foam metal cleaners. In addition, it engages in the manufacturing of bio-based materials; research and development, production, and sales of feed additives; technology research and development of bio-based materials; and research and development, and manufacturing of electronic special materials, as well as technical development, technical consultation, and technical services. The company also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603351.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025